Bavdegalutamide (ARV-110)

Bavdegalutamide (ARV-110) is an orally bioavailable, specific androgen receptor (AR) PROTAC degrader that leads to ubiquitination and degradation of AR. ARV-110 completely degrades androgen receptor (AR) in all cell lines tested with DC50 of < 1 nM. ARV-110 can be used for the research of prostate cancer.
Supplier Selleck Chemicals
Product # S6965
Sku # S6965-25mg
Pricing 25mg, $597.00
Feedback